News | Cardiovascular Business | July 01, 2024

CVRx Announces Key Senior Leadership Team Hires

Dr. Philip B. Adamson joins CVRx as Chief Medical Officer

Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed) has been appointed as Chief Medical Officer

Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed)


July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership team. Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed) has been appointed as Chief Medical Officer, Bonnie Handke, RN, MBA will assume the role of Senior Vice President of Patient Access, Reimbursement, and Healthcare Economics, and Jennifer E. Englund recently joined as Senior Vice President of Global Clinical Affairs. These roles will focus on driving the adoption of the company's Barostim therapy and expanding patient access.

"We are thrilled to welcome Dr. Adamson, Bonnie, and Jennifer to the CVRx leadership team. These three executives will play an important role as we seek to move our Barostim therapy towards standard of care," said Kevin Hykes, President and CEO of CVRx. "Dr. Adamson's deep expertise and relationships within the clinical community will be invaluable as we seek to drive awareness and appropriate adoption among clinicians. Bonnie's extensive experience in developing and executing market access strategies will be central in our efforts to expand patient access and secure favorable reimbursement. Jennifer's proven track record in leading successful clinical evidence generation strategies will be instrumental in further validating the efficacy of Barostim and supporting our pursuit of expanded indications.”

As Chief Medical Officer, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson joins CVRx from Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma. He will begin his employment at CVRx on May 23, 2024.

Watch the DAIC Thought Leadership Series: The Importance of Inclusion in Clinical Trials, featuring Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed) here

As Senior Vice President of Patient Access, Reimbursement, and Healthcare Economics, Bonnie Handke, RN, MBA, will lead CVRx's efforts to expand access to Barostim therapy. She is coming to CVRx from Medtronic, which she joined over 25 years ago as a Senior Manager in Neuromodulation and steadily progressed through roles of increasing responsibility, most recently serving as Vice President of Global Healthcare Economics, Policy and Reimbursement for the Cardiovascular portfolio. Handke has a proven track record of developing and executing market access strategies for numerous novel therapies, successfully navigating complex reimbursement landscapes. Handke earned an MBA from St. Thomas University, a BA from Concordia University, and an AS in Nursing from Normandale Community College. Bonnie will begin her new role on May 28, 2024.

Jennifer Englund joined CVRx as Senior Vice President of Global Clinical Affairs on May 1, 2024, overseeing the development and execution of the company's clinical evidence generation strategy, including designing and optimizing a pipeline of post-market studies. Englund brings over 25 years of experience in the medical device industry, most recently serving as Senior Vice President, Scientific Affairs at Monteris Medical, where she established a strong clinical portfolio that was pivotal in achieving reimbursement and clinical guideline status. She has also held clinical leadership roles at POPS! Diabetes Care, Mardil Medical, and Catheter Robotics. Englund holds a BS in Biology and BA in Psychology from the University of Minnesota.

For more information: www.cvrx.com

Watch the DAIC Thought Leadership Series: The Importance of Inclusion in Clinical Trials, featuring Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed) here

Related Barostim content:

Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure

CVRx Reports Preliminary Results of the BeAT-HF Post-Market Randomized Clinical Trial

Allegheny Health Network Cardiovascular Institute First in Pittsburgh to Implant Groundbreaking Neuromodulation Device as Alternative Therapy for Heart Failure Patients

Device Technologies to Reduce Heart Failure Readmissions 

Heart Rhythm Society 2019 Late-Breaking Clinical Trials 


Related Content

News | TCT

Oct. 11, 2024 – As the pace of change accelerates in healthcare, the most pressing questions in cardiovascular medicine ...

Home October 16, 2024
Home
News | TCT

November 9, 2023 — Medinbox, a global provider of video integrated collaboration systems for interventional rooms and ...

Home November 09, 2023
Home
News | TCT

October 30, 2023 — Shockwave Medical, Inc., which develops technologies for the treatment of cardiovascular disease, has ...

Home October 30, 2023
Home
News | TCT

October 26, 2023 — The Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgeons have issued ...

Home October 26, 2023
Home
News | TCT

October 26, 2023 — A new study presented at TCT 2023 revealed inequities in access to mechanical circulatory support in ...

Home October 25, 2023
Home
News | TCT

October 25, 2023 — Elixir Medical, developer of novel cardiovascular technologies, announced positive six-month clinical ...

Home October 25, 2023
Home
News | TCT

October 25, 2023 — Medtronic plc, a global leader in healthcare technology, announced four-year results from the Evolut ...

Home October 25, 2023
Home
News | TCT

October 25, 2023 — Information on a new double lumen catheter was presented by Nabil Dib, MD, MSc, FACC, FESC, during ...

Home October 25, 2023
Home
News | TCT

October 25, 2023 — For its novel multi-lumen stent system for interventional adjustment of pulmonary blood flow in ...

Home October 25, 2023
Home
Feature | TCT | By Melinda Taschetta-Millane

Innovation. Connection. Inspiration. The Transcatheter Cardiovascular Therapeutics (TCT) 2023 conference, the ...

Home October 20, 2023
Home
Subscribe Now